Impairment of superoxide dismutase activation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line

Biochemical and Biophysical Research Communications

Volumn 308, Issue 3, 2003, Pages 660-667

  Sakudo, Akikazu ^a   Lee, Deug Chan ^a   Saeki, Keiichi ^a   Nakamura, Yuko ^a   Inoue, Keiichi ^b   Matsumoto, Yoshitsugu ^a   Itohara, Shigeyoshi ^b   Onodera, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Antioxidant; Apoptosis; Caspase; Oxidative stress; Prion disease; Prion protein; PrP deficient cell line; Superoxide dismutase

Indexed keywords

CASPASE 3; CASPASE 9; OCTAPEPTIDE; PRION PROTEIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DELETION MUTANT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; UPREGULATION; WILD TYPE;

EID: 0041664024     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01459-1     Document Type: Article

References (34)

1. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA. 95:1998;13363-13383.
2. Bendheim P.E., Brown H.R., Rudelli R.D., Scala L.J., Goller N.L., Wen G.Y., Kascsak R.J., Cashman N.R., Bolton D.C. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein. Neurology. 42:1992;149-156.
3. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H.P., DeArmond S.J., Prusiner S.B., Aguet M., Weissmann C. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature. 356:1992;577-582.
4. Bueler H., Aguzzi A., Sailer A., Greiner R.A., Autenried P., Aguet M., Weissmann C. Mice devoid of PrP are resistant to scrapie. Cell. 73:1993;1339-1347.
5. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., Aguzzi A. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature. 379:1996;339-343.
6. Giese A., Brown D.R., Groschup M.H., Feldmann C., Haist I., Kretzschmar H.A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8:1998;449-457.
7. Rossi D., Cozzio A., Flechsig E., Klein M.A., Rulicke T., Aguzzi A., Weissmann C. Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J. 20:2001;694-702.
8. Manson J.C., Clarke A.R., Hooper M.L., Aitchison L., McConnell I., Hope J. 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol. Neurobiol. 8:1994;121-127.
9. Sakaguchi S., Katamine S., Nishida N., Moriuchi R., Shigematsu K., Sugimoto T., Nakatani A., Kataoka Y., Houtani T., Shirabe S., Okada H., Hasegawa S., Miyamoto T., Noda T. Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature. 380:1996;528-531.
10. Moore R.C., Lee I.Y., Silverman G.L., Harrison P.M., Strome R., Heinrich C., Karunaratne A., Pasternak S.H., Chishti M.A., Liang Y., Mastrangelo P., Wang K., Smit A.F., Katamine S., Carlson G.A., Cohen F.E., Prusiner S.B., Melton D.W., Tremblay P., Hood L.E., Westaway D. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J. Mol. Biol. 292:1999;797-817.
11. Yokoyama T., Kimura K.M., Ushiki Y., Yamada S., Morooka A., Nakashiba T., Sassa T., Itohara S. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol. Chem. 276:2001;11265-11271.
12. Tobler I., Gaus S.E., Deboer T., Achermann P., Fischer M., Rulicke T., Moser M., Oesch B., McBride P.A., Manson J.C. Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature. 380:1996;639-642.
13. Collinge J., Whittington M.A., Sidle K.C., Smith C.J., Palmer M.S., Clarke A.R., Jefferys J.G. Prion protein is necessary for normal synaptic function. Nature. 370:1994;295-297.
14. Herms J.W., Kretzchmar H.A., Titz S., Keller B.U. Patch-clamp analysis of synaptic transmission to cerebellar Purkinje cells of prion protein knockout mice. Eur. J. Neurosci. 7:1995;2508-2512.
15. Lledo P.M., Tremblay P., DeArmond S.J., Prusiner S.B., Nicoll R.A. Mice deficient for prion protein exhibit normal neuronal excitability and synaptic transmission in the hippocampus. Proc. Natl. Acad. Sci. USA. 93:1996;2403-2407.
16. Kuwahara C., Takeuchi A.M., Nishimura T., Haraguchi K., Kubosaki A., Matsumoto Y., Saeki K., Yokoyama T., Itohara S., Onodera T. Prions prevent neuronal cell-line death. Nature. 400:1999;225-226.
17. Borner C. The Bcl-2 protein family: sensors and checkpoints for life- or-death decisions. Mol. Immunol. 39:2003;615-647.
18. Cryns V., Yuan J. Proteases to die for. Genes Dev. 12:1998;1551-1570.
19. Brown D.R., Schulz-Schaeffer W.J., Schmidt B., Kretzschmar H.A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146:1997;104-112.
20. Waggoner D.J., Drisaldi B., Bartnikas T.B., Casareno R.L., Prohaska J.R., Gitlin J.D., Harris D.A. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275:2000;7455-7458.
21. Wong B.S., Pan T., Liu T., Li R., Gambetti P., Sy M.S. Differential contribution of superoxide dismutase activity by prion protein in vivo. Biochem. Biophys. Res. Commun. 273:2000;136-139.
22. Klamt F., Dal-Pizzol F., Conte da Frota M.J., Walz R., Andrades M.E., da Silva E.G., Brentani R.R., Izquierdo I., Fonseca Moreira J.C. Imbalance of antioxidant defense in mice lacking cellular prion protein. Free Radic. Biol. Med. 30:2001;1137-1144.
23. Rachidi W., Vilette D., Guiraud P., Arlotto M., Riondel J., Laude H., Lehmann S., Favier A. Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J. Biol. Chem. 278:2003;9064-9072.
24. Zeng F., Watt N.T., Walmsley A.R., Hooper N.M. Tethering the N-terminus of the prion protein compromises the cellular response to oxidative stress. J. Neurochem. 84:2003;480-490.
25. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:1987;947-950.
26. Narayanan P.K., Goodwin E.H., Lehnert B.E. Alpha particles initiate biological production of superoxide anions and hydrogen peroxide in human cells. Cancer Res. 57:1997;3963-3971.
27. Imrich A., Ning Y.Y., Kobzik L. Intracellular oxidant production and cytokine responses in lung macrophages: evaluation of fluorescent probes. J. Leukoc. Biol. 65:1999;499-507.
28. Johnson A.L., Bridgham J.T., Jensen T. Bcl-X(LONG) protein expression and phosphorylation in granulosa cells. Endocrinology. 140:1999;4521-4529.
29. Brown D.R., Wong B.S., Hafiz F., Clive C., Haswell S.J., Jones I.M. Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344:1999;1-5.
30. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
31. Pauly P.C., Harris D.A. Copper stimulates endocytosis of the prion protein. J. Biol. Chem. 273:1998;33107-33110.
32. Shyng S.L., Moulder K.L., Lesko A., Harris D.A. The N-terminal domain of a glycolipid-anchored prion protein is essential for its endocytosis via clathrin-coated pits. J. Biol. Chem. 270:1995;14793-14800.
33. Bounhar Y., Zhang Y., Goodyer C.G., LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J. Biol. Chem. 276:2001;39145-39149.
34. Zanata S.M., Lopes M.H., Mercadante A.F., Hajj G.N., Chiarini L.B., Nomizo R., Freitas A.R., Cabral A.L., Lee K.S., Juliano M.A., de Oliveira E., Jachieri S.G., Burlingame A., Huang L., Linden R., Brentani R.R., Martins V.R. Stress-inducible protein 1 is a cell surface ligand for cellular prion that triggers neuroprotection. EMBO J. 21:2002;3307-3316.